TuHURA Biosciences, Inc. (HURA)

NASDAQ: HURA · Real-Time Price · USD

2.910

-0.320 (-9.91%)

At close: Apr 1, 2025, 4:00 PM

3.094

+0.184 (6.33%)

After-hours: Apr 1, 2025, 7:59 PM EDT

TuHURA Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-18.37	-29.32	-9.37
Depreciation & Amortization	0.14	0.18	0.37
Other Amortization	1.11	0.01	-
Asset Writedown & Restructuring Costs	0.02	16.22	-
Stock-Based Compensation	0.97	0.48	0.22
Other Operating Activities	0.31	-	-0.29
Change in Accounts Payable	0.7	0.34	1.85
Change in Other Net Operating Assets	-0.04	0.15	-0.29
Operating Cash Flow	-15.16	-11.95	-7.51
Capital Expenditures	-0.08	-1.3	-0.04
Investing Cash Flow	-5.27	-1.3	-0.04
Long-Term Debt Issued	-	2.69	-
Long-Term Debt Repaid	-	-	-0.35
Net Debt Issued (Repaid)	31.25	2.69	-0.35
Repurchase of Common Stock	-	-0.02	-
Financing Cash Flow	35.97	2.66	16.25
Net Cash Flow	15.55	-10.59	8.71
Free Cash Flow	-15.24	-13.25	-7.54
Free Cash Flow Per Share	-0.20	-0.20	-
Levered Free Cash Flow	-	-8.29	-
Unlevered Free Cash Flow	-	-8.29	-
Change in Net Working Capital	-	-0.82	-

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q